Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.

BACKGROUND: Leukocyte depletion at the time of transplantation with alemtuzumab (Campath-1H) has been demonstrated to be a potential strategy for reducing long-term exposure to immunosuppressive drugs. Although the impact of alemtuzumab treatment on the immune system has been explored, the effects o...

詳細記述

書誌詳細
主要な著者: Hester, J, Mills, N, Shankar, S, Carvalho-Gaspar, M, Friend, P, Wood, K
フォーマット: Journal article
言語:English
出版事項: 2011